Significantly, our data demonstrate that pharmacological inhibition of USP7 with P22077 induces the degradation of MGMT, XPC, ALKBH2, and ALKBH3, consequently impairing all three major alkylation repair pathways in GBM cells. This evidence concerns the gene ALKBH2 and glioblastoma.